The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.89
Bid: 3.60
Ask: 4.18
Change: 0.00 (0.00%)
Spread: 0.58 (16.111%)
Open: 3.89
High: 0.00
Low: 0.00
Prev. Close: 3.89
TAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Snorkel Investment Update

15 Nov 2022 09:54

RNS Number : 4528G
Tanfield Group PLC
15 November 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain

 

 

Tanfield Group Plc

("Tanfield" or the "Company")

 

Snorkel Investment Update

 

 

The Board of Tanfield (the "Board") is pleased to update the market on its investment in Snorkel International Holdings LLC ("Snorkel"), the aerial work platform business.

 

 

Investment Background

 

· Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme Manufacturing LLC ("Xtreme") (the "Contemplated Transaction"), a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

· The Snorkel investment is valued at £19.1m. The outcome of the US Proceedings referenced below could have an impact on this valuation.

 

· On 22 October 2019, the Company announced that it had received a Summons and Complaint, filed in Nevada (the "US Proceedings") by subsidiaries of Xtreme, relating to the Contemplated Transaction.

 

· On 24 October 2019, the Company announced it had become necessary to issue and serve a claim in the English High Court (the "UK Proceedings") against its former solicitors acting for the Company at the time of the Contemplated Transaction. 

 

· On 18 October 2022, the Company announced that it had fully settled its claim in relation to the UK Proceedings on a no-fault basis for a total of £6.9m.

 

 

Highlights

 

· In the third quarter of 2022, Snorkel's sales increased slightly to US$42.4m, compared to US$42.2m for the third quarter of 2021. This resulted in sales for the first 9 months of 2022 being US$131.0m, compared to US$113.9m for the same period in 2021, an increase of 15.0%.

 

· The EBITDA for the third quarter of 2022 was a loss of US$3.1m, compared to a loss of US$2.8m for the third quarter of 2021. Despite the 15% increase in sales for the first 9 months of 2022, which amounted to £17.1m of additional sales, the EBITDA loss for the first 9 months of 2022 increased to US$10.9m, compared to US$5.3m for the same period in 2021. 

 

 

Business Update

 

Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme, a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

In the third quarter of 2022, Snorkel's sales increased slightly to US$42.4m, compared to US$42.2m for the third quarter of 2021. While Snorkel's recovery from the impact of the global COVID-19 pandemic has slowed in the third quarter, sales for the first 9 months of 2022 increased to US$131.0m, compared to US$113.9m for the same period in 2021, an increase of 15.0%.

 

The EBITDA for the third quarter of 2022 was a loss of US$3.1m, compared to a loss of US$2.8m for the third quarter of 2021. Despite the 15% increase in sales for the first 9 months of 2022, which amounted to £17.1m of additional sales, the EBITDA loss for the first 9 months of 2022 increased to US$10.9m, compared to US$5.3m for the same period in 2021. While the Board note that the gross profit margin has increased slightly in the third quarter of 2022 to 6.9%, compared to 2.8% in the second quarter of 2022, the gross profit margin for the first 9 months of 2022 is only 4.6%. The Board continues to believe that the gross profit margins are not in line with the industry averages and work to investigate this is ongoing.

 

Below is a summary of the consolidated financial statement for the third quarter and year to date of 2022, including comparative figures for 2021:

 

US$000's

Q3 2022

YTD 2022

 

Q3 2021

YTD 2021

 

 

 

 

 

Net sales

42,422

130,976

 

42,203

113,920

Cost of goods sold

39,487

125,001

40,120

106,246

Gross profit

2,935

5,975

2,083

7,674

6.9%

4.6%

4.9%

6.7%

 

 

 

Selling, general & administrative costs

4,945

14,814

4,865

12,722

Foreign currency exchange (gain)/loss

1,125

2,040

36

248

 

 

 

 

EBITDA profit/(loss)

(3,135)

(10,879)

 

(2,818)

(5,296)

 

 

 

Depreciation & non-operating costs

650

1,831

671

1,829

 

 

 

 

Net profit/(loss)

(3,785)

(12,710)

 

(3,489)

(7,125)

 

 

The Board views the year-to-date increase in sales as a positive development

 

 

The Company are now focussing on the US Proceedings which are continuing, with a jury trial currently expected to take place around the summer of 2023. 

 

The Board continue to believe that a positive outcome to the US Proceedings is possible. So far as it is necessary, the Company will continue to vigorously defend its position, whilst continuing to seek advice. 

 

Further updates will be provided to Shareholders as and when appropriate.

 

 

 

For further information:

 

Tanfield Group Plc 020 7220 1666

Daryn Robinson

 

WH Ireland Limited - Nominated Advisor / Broker

James Joyce / Megan Liddell 020 7220 1666

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFESUIEESEIF
Date   Source Headline
26th Apr 20061:30 pmRNSPreliminary Results
13th Mar 20062:06 pmRNSResult of EGM
30th Jan 20063:36 pmRNSDirector/PDMR Shareholding
27th Jan 20067:01 amRNSTrading Update
4th Jan 20064:24 pmRNSHolding(s) in Company
4th Jan 20064:23 pmRNSHolding(s) in Company
21st Dec 20059:30 amRNSContract Wins
20th Dec 20054:36 pmRNSPlacing Update
19th Dec 20057:00 amRNSPlacing
1st Dec 20057:01 amRNSChina Joint Venture
24th Nov 20057:01 amRNSDistribution and New Product
9th Nov 20057:00 amRNSResult of EGM
18th Oct 20052:55 pmRNSDirector/PDMR Shareholding
14th Oct 20051:58 pmRNSDirector/PDMR Shareholding
5th Oct 20057:00 amRNSDairy Crest Contract Win
30th Sep 20057:00 amRNSInterim Results
29th Sep 20057:00 amRNSDairy Crest Contract
29th Jul 200510:12 amRNSDirector/PDMR Shareholding
19th Jul 200512:34 pmRNSDirector/PDMR Shareholding
13th Jul 20057:00 amRNSContract Win
29th Jun 200511:15 amRNSConversion of loan stock
21st Jun 200510:43 amRNSDirector Shareholding
15th Jun 20052:45 pmRNSDirector Shareholding
9th Jun 20054:29 pmRNSDirector Declaration
9th Jun 20057:00 amRNSAcquisition
20th May 200512:02 pmRNSResult of EGM
5th May 20057:00 amRNSStrategic Opportunities
28th Apr 20058:30 amRNSEGM Notice / Issue of Equity
20th Apr 20052:14 pmRNSHolding(s) in Company
4th Apr 20057:01 amRNSPreliminary Results
21st Mar 200512:27 pmRNSHolding(s) in Company
18th Mar 20053:12 pmRNSHolding(s) in Company
14th Mar 20057:00 amRNSMajor contract win
7th Mar 20057:00 amRNSRe Contract
1st Mar 20057:00 amRNSContract Wins
28th Feb 20057:00 amRNSMemorandum of Understanding
27th Jan 20057:00 amRNSTrading Statement
11th Jan 20054:45 pmRNSHolding(s) in Company
11th Jan 20054:39 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.